Darifenacin Hydrobromide

Overview

Darifenacin Hydrobromide is an antimuscarinic drug used to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. It works by inhibiting the M3 muscarinic acetylcholine receptor, which relaxes bladder smooth muscle.

API suppliers (16)

Suppliers of Darifenacin Hydrobromide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Cipla USA, Inc.USA1 active DMF
• Cipla USA, Inc.USA1 active DMF
• TAPI NL BV1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• TAPI NL BV1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Apotex Inc.Canada1 active DMF
• ALIVUS LIFE SCIENCES LTD1 active DMF
• ALIVUS LIFE SCIENCES LTD1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• Dr. Reddy's Laboratories Ltd.India
• Zakłady Farmaceutyczne Polpharma S.A.Poland
• MYLAN LABORATORIES LTD
• INTERQUIM SA
• UNIMARK REMEDIES LTD

Therapeutic areas